G. Kelly Martin Net Worth

The estimated Net Worth of G. Kelly Martin is at least $1.27 Million dollars as of 29 May 2019. Mr Martin owns over 1,500 units of Radius Recycling stock worth over $660,600 and over the last 8 years he sold RDUS stock worth over $0. In addition, he makes $612,367 as CEO and Pres & Director at Radius Recycling.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

or

Sign up with Google Sign up with Facebook

Mr Martin RDUS stock SEC Form 4 insiders trading

Mr has made over 5 trades of the Radius Recycling stock since 2018, according to the Form 4 filled with the SEC. Most recently he bought 1,500 units of RDUS stock worth $2,955 on 29 May 2019.

The largest trade he's ever made was buying 60,000 units of Radius Recycling stock on 17 May 2019 worth over $85,800. On average, Mr trades about 8,077 units every 22 days since 2016. As of 29 May 2019 he still owns at least 45,000 units of Radius Recycling stock.

You can see the complete history of Mr Martin stock trades at the bottom of the page.

Mr. G. Kelly Martin biography

G. Kelly Martin is the CEO, Pres & Director at Radius Recycling.

What is the salary of Mr Martin?

As the CEO and Pres & Director of Radius Recycling, the total compensation of Mr Martin at Radius Recycling is $612,367. There are 2 executives at Radius Recycling getting paid more, with Charles Morris having the highest compensation of $1,660,660.

How old is Mr Martin?

Mr Martin is 62, he's been the CEO and Pres & Director of Radius Recycling since . There are 2 older and 9 younger executives at Radius Recycling. The oldest executive at Radius Recycling Inc. is Dr. John Thomas Potts Jr., DSc, M.D., 89, who is the Founder & Member of the Scientific Advisory Board.

What's Mr Martin's mailing address?

G's mailing address filed with the SEC is C/O RADIUS HEALTH, INC., 22 BOSTON WHARF ROAD, 7TH FLOOR, BOSTON, MA, 02210.

Insiders trading at Radius Recycling

Over the last 12 years, insiders at Radius Recycling have traded over $1,066,622 worth of Radius Recycling stock and bought 11,047,648 units worth $180,729,288 . The most active insiders traders include Target N Vbb Biotech Ag Bio..., Growth N Vbb Biotech Ag Bio..., and Capital Management Lp Rosen.... On average, Radius Recycling executives and independent directors trade stock every 34 days with the average trade being worth of $1,552,483. The most recent stock trade was executed by Stefano R. Gaggini on 6 May 2024, trading 1,021 units of RDUS stock currently worth $18,960.

What does Radius Recycling do?

founded in 1906 as a one-man scrap metal operation, schnitzer steel industries, inc., has become one of the nation's largest recyclers of scrap metal, a leading provider of used and recycled auto parts and a manufacturer of finished steel products. with a rapidly growing national and global reach, the company achieved $2.5 billion in revenues in fiscal 2014 and was ranked #853 in the 2015 fortune 1000 list of companies. schnitzer steel common stock is traded on the nasdaq stock market under the symbol schn. with corporate headquarters based in portland, oregon, the company is split into three vertically integrated business units, the metals recycling business, the auto parts business and the steel manufacturing business. career site: http://www.schnitzersteel.com/careers.aspx

Complete history of Mr Martin stock trades at Novan Inc and Radius Recycling

Radius Recycling executives and stock owners

Radius Recycling executives and other stock owners filed with the SEC include:

• Charles Morris,
  Chief Medical Officer
• Chhaya Shah,
  Sr. VP & Chief Bus. Officer
• G. Kelly Martin,
  CEO, Pres & Director
• Salvador Grausso III,
  Sr. VP & Head of U.S. Patient access
• Danielle Holtschlag,
  VP of Sales & Head of U.S. Sales Channels
• Owen Hughes,
  Independent Chairman of the board
• Elhan Webb,
  Investor Relations
• Sean Murphy,
  Director
• Chhaya Shah,
  Senior Vice President - Technical Operations
• Dan Dolan,
  Principal Financial Officer, Principal Accounting Officer, Treasurer
• G. Kelly Martin,
  President, Chief Executive Officer, Director
• Peter A. Schwartzman,
  Head of Corp. Fin.
• Mark William Conley CPA,
  VP, CFO, Principal Accounting Officer & Treasurer
• Averi Price,
  Gen. Counsel, Chief Compliance Officer & Sec.
• Ethan Holdaway,
  Head of Investor Relations
• Steven Helwig,
  Principal Fin. & Accounting Officer and Interim Treasurer
• Dr. John A. Katzenellenbogen,
  Founder & Member of the Scientific Advisory Board
• Dr. Michael Rosenblatt M.D.,
  Founder, Board Observer & Member of Scientific Advisory Board
• Dr. John Thomas Potts Jr., DSc, M.D.,
  Founder & Member of the Scientific Advisory Board
• Dr. Stavros C. Manolagas,
  Founder & Member of the Scientific Advisory Board
• Growth N Vbb Biotech Ag Bio...,
  
• Lorraine A. Fitzpatrick,
  Chief Medical Officer
• Alan H Auerbach,
  Director
• Bio Ventures Iv Llc Scopa J...,
  
• Ansbert Gadicke,
  Director
• Robert Ward,
  President & Chief Exec Officer
• Gregory C. Williams,
  Chief Development Officer
• Debasish Roychowdhury,
  Director
• Brent Hatzis Schoch,
  Sr. VP, General Counsel
• Kurt Graves,
  Director
• Cathy Friedman,
  Director
• Willard H Dere,
  Director
• Bioventures Iii Llchenner D...,
  
• Luke Evnin,
  10% owner
• Dinesh Purandare,
  SVP,Global Oncology/Commercial
• David P. Snow,
  Chief Commercial Officer
• Jose Carmona,
  Chief Financial Officer
• Anthony Rosenberg,
  Director
• Jean Pierre Garnier,
  Director
• Nicholassimon Nicholas J Ii...,
  
• Gary Hattersley,
  Sr. VP & Chief Scientific Off.
• Brian Nicholas Harvey,
  Sr. Vice President & CFO
• Gregory R Friedman,
  
• Rhonda D Hunter,
  
• David L Jahnke,
  
• Jesper Hoeiland,
  President and CEO
• Danielle Holtschlag,
  Vice President, Sales
• Joseph Francis Kelly,
  Sr. VP of Sales and Marketing
• Jessica Hopfield,
  Director
• Glenda J Minor,
  
• Michael W Sutherlin,
  
• Bioscience Iii, L.P.F2 Bios...,
  
• Martin Muenchbach,
  Director
• Morana Jovan Embiricos,
  Director
• Bioscience Iv L.P.F2 Biosci...,
  
• Bioscience Iii, L.P.F2 Bios...,
  
• Alan G Harris,
  Executive Medical Officer
• Elizabeth Stoner,
  Director
• Bioventures Iii Llchenner D...,
  
• Bioscience Iv L.P.F2 Biosci...,
  
• Mark Durand,
  Chief Commercial Officer
• Bio Ventures Iv Llc Scopa J...,
  
• Bio Ventures Iv Llc Scopa J...,
  
• Bioventures Iii Llcmpm Biov...,
  
• Leslie L Shoemaker,
  
• Target N Vbb Biotech Ag Bio...,
  
• Machelle Sanders,
  Director
• Sal Grausso,
  Chief Commercial Officer
• James George Chopas,
  Principal Finance Accounting
• Steven Helwig,
  Principal Financial Officer
• Capital Management Lp Rosen...,
  
• Mark William Conley,
  VP, Chief Financial Officer
• Susan Vissers Lisa,
  Director
• Jennifer Jarrett,
  Director
• Elizabeth Messersmith,
  Senior Vice President
• Tamara L. Lundgren,
  Chairman, President & CEO
• James Matthew Vaughn,
  SVP, GC, CCO, Corp. Secretary
• Steven Heiskell,
  SVP & President, Recycling P&S
• Mark Schuessler,
  VP and CAO
• Brian Souza,
  SVP, Chief Ops Mgmt Officer
• Richard Peach,
  EVP, Chief Strategy Officer
• Wilson D Erich,
  SVP, Chief HR Officer
• Stefano R. Gaggini,
  SVP, CFO